STING1 and hepatocellular carcinoma: Relevantly, besides the immunotherapy setting, the gut microbiota has also been reported to modulate radiotherapy-associated antitumor immune responses against HCC via regulating the stimulator of interferon genes (STING) signaling, proposing the modulation of the microbiome as a potential enhancer of radiotherapy efficacy [129].